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Background: One-lung ventilation (OLV) is a ventilation procedure used for pulmonary resection which 
may results in lung injury. The aim of this study was to evaluate the local inflammatory cytokine response 
from the dependent lung after OLV and its correlation to VT. The secondary aim was to evaluate the clinical 
outcome of each patient.
Methods: Twenty-eight consecutive patients were enrolled. Ventilation was delivered in volume-controlled 
mode with a VT based on predicted body weight (PBW). 5 cmH2O positive end-expiratory pressure (PEEP) 
and FiO2 0.5 were applied. Bronchoalveolar lavage (BAL) was performed in the dependent lung before and 
after OLV. The levels of pro-inflammatory interleukins (IL-1α, IL-1β, IL-6, IL-8), tumor necrosis factor 
alpha (TNFα), vascular endothelial growth factor (VEGF), endothelial growth factor (EGF), monocyte 
chemoattractant protein-1 (MCP-1) and anti-inflammatory cytokines, such as interleukins (IL-2, IL-4, 
IL-10) and interferon (IFN-γ), were evaluated. Subgroup analysis: to analyze the VT setting during OLV, 
all patients were ventilated within a range of 5–10 mL/kg. Thirteen patients, classified as a conventional 
ventilation (CV) subgroup, received 8–10 mL/kg, while 15 patients, classified as a protective ventilation (PV) 
subgroup, received 5–7 mL/kg.
Results: Cytokine BAL levels after surgery showed no significant increase after OLV, and no significant 
differences were recorded between the two subgroups. The mean duration of OLV was 64.44±21.68 minutes. 
No postoperative respiratory complications were recorded. The mean length of stay was for 4.00±1.41 days 
in the PV subgroup and 4.45±2.07 days in the CV group; no statistically significant differences were recorded 
between the two subgroups (P=0.511).
Conclusions: Localized inflammatory cytokine response after OLV was not influenced by the use of 
different VT. Potentially, the application of PEEP in both ventilation strategies and the short duration of 
OLV could prevent postoperative complications.
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Introduction
One-lung ventilation (OLV), routinely used in thoracic 
surgery to achieve optimal surgical exposure, has its own 
particular features and problems as compared to two-lung 
ventilation (TLV). OLV may cause vascular congestion 
and an inflammatory response resulting in potentially 
harmful effects on the pulmonary parenchyma (1). For 
years, hypoxia has been the most important issue during 
OLV, and its incidence is about 5–10% (2). During OLV, 
the perfusion/ventilation ratio in the non-dependent lung 
changes. An auto-compensatory response and hypoxic 
pulmonary vasoconstriction (HPV) occurs, distributing 
pulmonary capillary blood flow to areas of high-oxygen 
availability to optimize gas exchange (3). This mechanism 
causes extensive pulmonary vasoconstriction and associated 
vascular congestion (4). Furthermore, OLV determines the 
activation of the inflammatory response with a release of 
inflammatory mediators by the bronchial epithelium; this 
occurs both in the dependent and non-dependent lung (5), 
but mostly in the ventilated one (6). The most important 
issue concerning OLV is actually the development of 
postoperative respiratory complications, such as acute lung 
injury and acute respiratory distress syndrome (7); in fact, 
ALI and ARDS are the leading causes of death after lung 
resection. Elevated VT and airway pressure are associated 
with an increased incidence in these complications (8). For 
years, the use of large tidal volume (VT 8–10 mL/kg), zero 
end-expiratory pressure (ZEEP), and a high fraction of 
inspired oxygen (FiO2) during OLV had been recommended 
in order to not increase vascular resistance, to limit 
transpulmonary shunt and prevent the onset of atelectasis 
in the ventilated lung, ensuring arterial oxygenation and the 
elimination of CO2 (9,10). Recent studies have questioned 
the safety of the conventional ventilation (CV) strategy 
during OLV, due to a decrease in oxygenation, an increase in 
inflammatory products and reactive oxygen species resulting 
in damage to lung tissue (11,12). Several authors have 
demonstrated that the using a protective ventilation (PV) 
strategy with a small VT (4–6 mL/kg) reduces the incidence 
of postoperative ALI and ARDS in patients undergoing 
lung resection (13) and decreases the systemic inflammatory 
cytokine response as compared to CV (14,15). Since 
several studies evaluated the level of a systemic inflammatory 
response, that also depends on the extent of surgical trauma, 
lung cancer and comorbidities, the attribution of OLV to 
inflammatory response is not yet clear (16). It is assumed that 
OLV may initiate a pro-inflammatory response in the alveolar 
compartment of the dependent lung, nevertheless, pleural 
fluid measurement and bronchoalveolar lavage (BAL) yield 
disputable data (17). Thus far, most studies compared high VT 
without PEEP to low VT and PEEP; therefore, it is not known 
whether mechanical ventilation with PEEP and high VT could 
induce an inflammatory response. The aim of this study was 
to assess the local inflammatory cytokine response of the 
dependent lung and determine the causative role of VT in lung 
injury during OLV in patients undergoing lung resection. The 
secondary aim was to evaluate the possible correlation between 
inflammatory cytokine levels and postoperative respiratory 
complication occurrence and length of stay.
Methods
Patients and methods
The study was approved by the Bioethics Committee 
of Sapienza University of Rome (No. 3722_2015), and 
informed consent was obtained from each patient in writing 
prior to enrolment. From November to December 2016, 
thirty patients scheduled for elective lobectomy or wedge 
resection via thoracotomy were included in the study. 
Exclusion criteria were emergency surgery, pregnancy, 
patient refusal to give consent, inability to give consent, 
age ≤18 years and ASA ≥ IV. Two patients were excluded 
from the study due to changes in planned surgery and 
refusal to give consent. Preoperative data such as age, 
sex, weight, height, body mass index (BMI) and predicted 
body weight (PBW) were analyzed. The type of surgery, 
ASA score, forced expiratory volume in the first second 
(FEV1, % predicted), comorbidities and preoperative ABG 
(arterial blood gas) were considered. The intraoperative 
data such as the duration of OLV, total fluid infusions, 
VT, peak inspiratory pressure (P peak), plateau pressure 
(P plateau), compliance, end-tidal partial pressure of carbon 
dioxide (EtCO2), respiratory rate (RR), peripheral oxygen 
saturation (SpO2), systolic, diastolic, mean blood pressure 
and ABG were analyzed.
Anesthesia and surgery
Before surgery, patients received premedication with 
midazolam 0.03 mg/kg, ondansetron 8 mg, ketorolac 
t romethamine  30  mg,  dexamethasone  4  mg and 
pantoprazole 40 mg intravenously. Anesthesia was induced 
intravenously using propofol 1.5–2 mg/kg, fentanyl 
2 μg/kg and ketamine 0.3 mg/kg. Orotracheal intubation 
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was performed with a double lumen tube (DLT) after 
administration of rocuronium bromide 0.6 mg/kg. The 
correct positioning of the DLT was evaluated by fiberoptic 
bronchoscopy (FOB) following endotracheal intubation, 
and then, once the patient was positioned on lateral 
decubitus. Maintenance of general anesthesia was achieved 
with desflurane (minimum alveolar concentration MAC-1) 
and continuous infusion of remifentanil, using a target-
controlled infusion (TCI) system in effect-site target mode 
with an Alaris® PK Syringe Pump. The target effect-site 
concentration of remifentanil was calculated by a Minto 
pharmacokinetic set. Ventilation was performed in volume-
controlled mode, with 5 cmH2O PEEP, FiO2 of 0.5, a 1:2 
inspiratory-expiratory ratio and a RR of 12–18 breaths/min 
in order to maintain an end-tidal concentration of 
CO2 <40 mmHg. Prior to the opening of the chest wall and 
just after the positioning of the patient in lateral decubitus, 
OLV was immediately started with a VT calculated 
according to PBW and selected at the discretion of the 
operating room anesthesiologist. In the case of desaturation 
(SpO2 <90%), the DLT position would be verified with 
an FOB before progressively increasing the FiO2 by 10%; 
alveolar recruitment maneuvers would be made through 
manual inflations for 10–40 seconds to reach a peak pressure 
of 30–40 cm H2O. The maximum P peak on volume-
controlled ventilation would be set at 35 cmH2O. When 
this value was exceeded, volume-controlled ventilation 
would be changed to pressure-controlled ventilation, with 
a setting providing the same VT. Intraoperative monitoring 
would include a three-lead ECG, invasive blood pressure 
(IBP) continuously recorded via a-line, oxygen saturation by 
pulse oximetry (SpO2), and expired CO2. Arterial blood gas 
(ABG) analysis was performed every 30 minutes from the 
start of OLV. A moderate intravenous fluid management of 
5–6 mL/kg/h was used. The surgical approach was based on 
a muscle-sparing mini-thoracotomy. At the end of surgery, 
an intrapleural, intercostal nerve block was performed using 
20 mL of ropivacaine 0.5%. The chest tube insertion point 
and the thoracic wound were also infiltrated with 10 mL 
of ropivacaine 0.5%. Postoperative analgesia was delivered 
using a 24-hour continuous infusion of tramadol and 
ketorolac with an elastomeric pump. 
BAL analysis
BAL was performed selectively from the dependent lung 
immediately before and at the end of OLV (before start 
two lungs ventilation) by instilling 20 mL of sterile isotonic 
saline in the segments of the lower lobe of the dependent 
lung. During bronchoscopy, the FiO2 was kept at 1.0.
BAL was centrifuged (200 g, 4 ℃, 10 min) and aliquots 
from the clear supernatant were stored at 80 ℃ for analysis. 
The levels of pro-inflammatory interleukins (IL-1α, IL-1β, 
IL-6, IL-8), tumor necrosis factor-alpha (TNFα), vascular 
endothelial growth factor (VEGF), endothelial growth 
factor (EGF), monocyte chemoattractant protein-1 (MCP), 
and anti-inflammatory cytokines, such as interleukins 
(IL-2, IL-4, IL-10) and interferon (IFN-γ), were evaluated 
simultaneously using cytokine & growth factor arrays 
from Evidence Investigator Biochip Array technology® 
(Randox Laboratories, Crumlin, UK) according to the 
manufacturer’s instructions. The sensitivities of the test 
kits were as follows: IL-1α: 0.8 pg/mL, IL-1β: 1.6 pg/mL, 
IL-6: 1.2 pg/mL, IL-8: 4.9 pg/mL, TNFα: 4.4 pg/mL , 
VEGF:  14 .6  pg/mL,  EGF:  2 .9  pg/mL,  MCP-1 : 
13.2 pg/mL, IL-10: 1.8 pg/mL, IL-2: 4.8 pg/mL, IL-4: 
6.6 pg/mL, IL-10: 1.8 pg/mL, IFN-γ: 3.5 pg/mL.
Subgroup analysis
To analyze the VT set during OLV, each patient received 
5–10 mL/kg and two subgroups can be distinguished: a CV 
subgroup, comprised of 13 patients, received 8–10 mL/kg and 
a PV subgroup, comprised of 15 patients, received 5–7 mL/kg.
Statistics
The calculation of the sample size was based on previous 
studies (11,12,18,19) which took into account the tested 
hypothesis that cytokines would vary more than 25% after 
OLV with a power of 0.9; thus, a sample size of 30 patients 
was required. The Shapiro-Wilk test was used to assess 
the normality of distributions. Mean values and standard 
deviation (SD) were determined by Student’s t-test for 
each quantitative variable. Fisher exact test was applied for 
qualitative variables. The Mann-Whitney U-test was used 
when the distribution was non normal. Parameters with 
values deviating from a normal distribution were analyzed 
by the median lower quartile (Q1) and upper quartile 
(Q3). P values <0.05 were considered significant. The data 
was analyzed using the SPSS v20.0 software (SPSS Inc., 
Chicago, IL, USA).
Results
The study included 28 consecutive patients (14 females and 
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14 males), from 52–83 years of age, undergoing elective 
surgery for lung resection. There were no statistically 
significant differences in the demographic or clinical 
data among the patients and between the two ventilatory 
subgroups as illustrated in Table 1. Shown in Table 2 is 
the comparative intraoperative data for (I) the overall 
population analyzed thus far, (II) the CV subgroup, and 
(III) the PV subgroup. During mechanical ventilation, a 
higher ventilator rate was required to achieve an optimal 
EtCO2 range at 30 minutes of OLV in the PV subgroup as 
compared to the CV subgroup (RR 16.27±2.34 in the PV 
subgroup, 11.64±1.91 in the CV subgroup; P=0.001). At 
the same evaluation point, EtCO2 and PaCO2 were higher 
in the PV subgroup (EtCO2 30.00±4.92 mmHg in the CV 
subgroup, EtCO2 35.00±5.38 mmHg in the PV subgroup; 
P=0.036; PaCO2 39.36±4.52 mmHg in the CV subgroup, 
PaCO2 48.80±4.78 mmHg in the PV subgroup; P=0.001). 
Peak airway pressure was lower during mechanical 
ventilation with a small VT at 15 and 30 minutes in the 
PV subgroup (P peak 15 min 22.00±8.21 cmH2O, and 
P peak 30 min 26.00±7.04 cmH2O in the PV subgroup; 
P peak 15 min 29.00±5.12 cmH2O and P peak 30 min 
30.00±4.52 cmH2O in the CV subgroup; respectively 
P=0.016 and P=0.027). Plateau pressure was lower 
in the PV subgroup at 15 minutes (P plateau 15 min 
16.00±6.31 cmH2O in the PV subgroup; P plateau 
15 min 23.50±4.7 cmH2O in the CV subgroup; P=0.014). 
Peripheral oxygen saturation at 30 minutes was higher 
in  the CV subgroup (SpO 2% 30 min 95.00±2.98 
in  the  PV subgroup;  SpO 2% 30 min 98.00±1.86 
Table 1 Demographic and epidemiological data in the overall population, the CV subgroup and the PV subgroup
Parameter All (n=28) CV (n=13) PV (n=15) P value*
Gender (M/F) 14/14 6/7 8/7 0.724
Age (years) 66.44±9.35 64.37±8.97 68.10±9.78 0.319
BMI (kg/m2) 24.51±4.11 23.76±3.29 25.11±4.75 0.280
PBW (kg) 59.69±10.80 60.02±12.79 59.43±9.65 0.681
ASA (II/III) 12/16 6/7 6/9 0.999
PaO2/FiO2 ratio (mmHg) 385.29±70.03 363.22±85.60 398.53±58.0 0.683
PaO2 (mmHg) 85.29±15.80 87.78±21.13 83.80±12.18 0.692
FEV1 (% predicted) 103.47±22.89 100.69±21.79 105.70±24.67 0.995
Comorbidity
CAD 1/28 1/13 0/15 0.464
COPD 12/28 4/13 8/15 0.276
Diabetes 3/28 1/13 2/15 0.999
Hypertension 13/28 6/13 7/15 0.999
Smoking 10/28 5/13 5/15 0.999
Scheduled surgery
Lobectomy right 13 5 8 0.475
Lobectomy left 5 2 3 0.999
Wedge resection right 5 3 2 0.638
Wedge resection left 5 3 2 0.638
Pathology: squamous/adeno/other, (n) 2/16/10 1/6/6 1/10/4 0.701
*, P value by t-test or Fisher test, as appropriate. The data is expressed as mean ± SD or No. of patients. There are no differences between 
the subgroups. adeno, adenocarcinoma; ASA, American Society of Anesthesiologists; CAD, coronary artery disease; COPD, chronic 
obstructive pulmonary disease; FEV1%, predicted forced expiratory volume in 1 s; F, female; M, male; PaO2, arterial blood oxygen tension; 
PBW, predicted body weight; squamous, squamous cell carcinoma; CV, conventional ventilation; PV, protective ventilation.
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in the CV subgroup; P=0.027).  No postoperative 
respiratory complications were recorded, and no patient 
required postoperative admission to the ICU. The 
average length of a hospital stay was 4.19±1.69 days 
with no significant differences detected in PV patients 
as compared to CV patients (mean 4.00±1.41 days in PV 
subgroup vs. mean 4.45±2.07 days in the CV subgroup). 
Cytokine BAL levels are shown in Figures 1 and 2. 
The IFN-γ levels were below the detection threshold 
in 36/56 samples, whereas the IL-8 levels were above 
the upper limit of detection in 30/56 samples; for this 
reason, no further statistical analysis was performed for 
Table 2 Intraoperative and postoperative data for the overall studied population, the CV subgroup and the PV subgroup
Intraoperative and postoperative data All (n=28) CV (n=13) PV (n=15) P value*
OLV duration (min) 64.44±21.68 60.62±23.67 67.50±20.72 0.138
VT (mL) 430.83±174.64 591.87±131.58 302.00±51.43 0.001
VT [mL/kg (PBW)] 7.4 2±2.07 9.5±0.63 5.6±0.71 0.001
Fluids (mL·kg−1·h−1) 5.66±1.13 5.70±0.99 5.63±1.29 0.619
Compliance 15 min (mL/cm H2O) 27.28±10.93 24.62±9.88 29.4±11.77 0.536
Compliance 30 min (mL/cmH2O) 23.28±11.21 25.50±9.46 21.50±12.65 0.428
EtCO2 15 min (mmHg) 34.92±6.48 32.81±6.38 36.47±6.36 0.172
EtCO2 30 min (mmHg) 33.5± 5.35 30.00±4.92 35.00± 5.38 0.036
SpO2 15 min (%) 97.00±3.19 98.00±2.72 97.0±3.50 0.300
SpO2 30 min (%) 96.00±2.85 98.00±1.86 95.00± 2.98 0.027
P peak 15 min (cmH2O) 28.00±7.89 29.00±5.12 22.00±8.21 0.016
P peak 30 min (cmH2O) 29.00±6.84 30.00±4.52 26.00±7.04 0.027
P plateau 15 min (cmH2O) 21.00±6.28 23.50±4.7 16.00±6.31 0.014
P plateau 30 min (cmH2O) 23.00±5.48 25.00±5.4 22.00±4.91 0.87
MAP 15 min (mmHg) 85.08±12.60 88.91±13.72 82.27±11.36 0.208
MAP 30 min (mmHg) 75.88±12.21 77.27±12.49 74.87±12.34 0.629
HR 15 min (bpm) 64.46±10.03 62.18±7.36 66.13±11.57 0.328
HR 30 min (bpm) 60.50±11.57 56.55±6.99 63.4 ±13.52 0.138
PaO2 (mmHg, ABG 30 min) 117.73±51.10 99.64±28.79 131.00±60.21 0.102
PaCO2 (mmHg, ABG 30 min) 44.81±6.60 39.36±4.52 48.80±4.78 0.001
PaO2/FiO2 ratio (mmHg, ABG 30 min) 236.77±101.23 202.55±55.24 261.87±120.51 0.117
pH 7.39±0.07 7.44±0.23 7.33±0.04 0.098
HCO3
− (mmol/L) 27.30±2.45 26.38±2.52 25.11±1.91 0.60
RR 15 min (bpm) 12.00± 2.73 12.00±1.73 14.00± 2.97 0.427
RR 30 min (bpm) 14.31±3.16 11.64±1.91 16.27±2.34 0.001
Length of stay (days) 4.19±1.69 4.45±2.07 4.00±1.41 0.511
The data is expressed as mean ± SD (95% CI). *, P value by t-test or Mann-Whitney U test, as appropriate. Compliance is respiratory 
system compliance. HR, heart rate; EtCO2, end-tidal partial pressure of carbon dioxide; MAP, mean arterial pressure; OLV, one-lung 
ventilation; PaCO2, arterial blood carbon dioxide tension; PaO2, arterial blood oxygen tension; P peak, peak airway pressure; P plateau, 
plateau airway pressure; RR, respiratory rate; SpO2, peripheral oxygen saturation; VT, tidal volume; CV, conventional ventilation; PV, 
protective ventilation.
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Figure 1 Differences and changes in pro-inflammatory (IL-1α, IL-1β, IL-6, TNFα, VEGF, EGF, MCP-1) cytokines BAL levels before 
(PRE) and after surgery (POST) in CV and PV subgroups. No significant differences between two subgroups. IL, interleukin; TNF, tumor 
necrosis factor; VEGF, vascular endothelial growth factor; EGF, endothelial growth factor; MCP-1, monocyte chemoattractant protein-1; 
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these cytokines. The cytokine levels measured in BAL 
after OLV did not significantly increase or decrease and 
the levels were not appreciably different between the two 
subgroups.
Discussion
In our study, designed to evaluate the effects of OLV on 
local cytokine inflammatory response, we did not observe 
consistent differences in pro-inflammatory and anti-
inflammatory levels of cytokine in BAL. Our findings, 
therefore, appear to be in contrast with previous data 
indicating that OLV initiates a pro-inflammatory response 
in the alveolar compartment of the dependent lung and that 
the use of higher airway pressures and VT during OLV is 
associated with the development of ALI (11,20,21).
Mechanical ventilation may exacerbate or initiate 
lung injury, processes defined as ventilator-associated or 
ventilator-induced lung injury (VALI and VILI) (20). OLV 
may be an exemplary model of VILI, because OLV itself 
is characterized by a diminished available lung volume for 
ventilation, atelectasis and impaired oxygenation which 
result in the exposure of the ventilated lung to volutrauma 
and atelectrauma (22). OLV is a non-physiologic condition 
that can result in histologic lung injury, involving the entire 
alveolar-capillary unit (7) and inducing an inflammatory 
response in both the non-dependent and dependent 
lungs, but mostly in the ventilated one (5). The use of 
a larger VT and higher airway pressures during OLV is 
associated with the development of ALI and ARDS (8). 
These are well-known leading causes of mortality after 
lung resection and significantly reduce 1-year survival rates 
(56% vs. 92%) (11). The study of Yang et al. showed that 
the application of a small VT and PEEP was associated with 
a lower incidence of postoperative lung dysfunction and 
satisfactory gas exchange compared with the traditional 
large VT ventilation (13). Schilling et al. (17) demonstrated 
that OLV with a large VT may promote the production and 
release of pro-inflammatory substances, such as TNF-alpha 
and Intercellular Adhesion Molecule 1 (ICAM-1) in the 
dependent lung, but they did not correlate the level of 
these molecules with patient outcomes and clinical data. 
Michelet et al. (14) proved that PV strategy diminishes the 
pro-inflammatory systemic response and the release of IL-1, 
IL-6, and IL-8 after a prolonged period of OLV and ensures 
better oxygenation and a shorter duration of postoperative 
ventilation.
Certain data suggests that mechanical ventilation 
appears to induce no inflammation in normal lungs, but 
may increase lung inflammation in pre-injured or infected 
lungs. Tremblay et al. (23) found that injurious mechanical 
ventilation causes elevated production of cytokines in 


















































Figure 2 Differences and changes in anti-inflammatory cytokines 
BAL levels (IL-2, IL-4, IL-10) before (PRE) and after surgery 
(POST) in CV and PV subgroups. No significant differences 
between two subgroups. BAL, bronchoalveolar lavage; PRE, 
preoperative; POST, postoperative; CV, conventional ventilation; 
PV, protective ventilation.
1871Journal of Thoracic Disease, Vol 10, No 3 March 2018
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(3):1864-1874jtd.amegroups.com
whereas in the absence of this inflammatory co-stimulus, 
there was no induction of TNFα and IL-6. In rats without 
lung injury, mechanical ventilation with a VT set at 
10 mL/kg did not affect cytokine release [IL-1α, IL-1β, 
IL-6, macrophage inflammatory protein (MIP) 2, 
and TNFα ]  in BAL f luid as  compared to that  of 
spontaneous breathing (24). On the other hand, in a 
rat model with hydrochloric acid instillation–induced 
lung injury, mechanical ventilation with a VT of 16 mL 
and ZEEP resulted in a marked increase of TNFα and 
MIP-2 as compared to a VT of 9 mL and 5 cmH2O 
PEEP (25). Wrigge et al. (26) demonstrated that mechanical 
ventilation with a large VT and ZEEP did not result in 
higher cytokine levels as compared to PV strategies and that 
previous lung damage seems to be a prerequisite for the 
release of cytokines. 
In our study, the application of PEEP may have played 
a protective role against inflammation. Thus far, no studies 
have demonstrated a definitive, specific advantage of a small 
VT ventilation per se in the absence of other protective 
ventilatory strategies as in the application of PEEP, airway 
pressure limitation and recruitment maneuvers. It is not yet 
clear, therefore, which ventilator parameter is most likely 
to prevent respiratory complications. Treschan et al. (27) 
demonstrated that there are no differences in postoperative 
pulmonary function between large and small VT regimens, 
both employing equally moderate levels of PEEP. Other 
studies demonstrated an association between small 
intraoperative VT with minimal PEEP and an increased risk 
of mortality and postoperative complications: low PEEP 
appears to be insufficient to stabilize alveoli, reduce alveolar 
strain, and prevent atelectasis (28,29). Application of 
PEEP is essential to safeguard the lung in surgical patients 
ventilated with both small and large VT, by improving 
lung function and reducing the risk of postoperative 
complications after OLV (13,14,30). In light of the current 
evidence, it could be suggested that a small VT does not 
in itself prevent postoperative respiratory complications 
without adequate PEEP, and it is interesting to note that in 
the most important studies, the duration of OLV was longer 
than that used in the present study (Table 3). The duration 
of OLV, in fact, is one of the primary factors in determining 
a pulmonary inflammatory response, and a significant 
correlation between a pulmonary inflammatory response 
and the duration of OLV has been demonstrated by several 
studies: De Conno et al. showed a positive correlation 
between cytokines release and OLV duration (31); 
Tekinbas et al. (32) demonstrated that, in a rat model, 
lung tissue myeloperoxidase activity, alveolar edema and 
infiltration with inflammatory cells increased in function to 
OLV time. These findings were also supported by Misthos 
et al. (33) which showed that the degree of oxidative stress 
was also related to the duration of OLV. The use of short-
term OLV is the probable explanation for the absence of the 
production of inflammatory mediators in our experiment, 
which ultimately begins after an hour of OLV. The duration 
of OLV seems to be one of the major factors influencing a 
patients’ outcome, aside from the quality of postoperative 
analgesia and intraoperative fluid therapy, in positive 
correlation with the length of an ICU stay (34). If put into 
practice, approaches and techniques that would achieve 
the optimization of these factors could improve patient 
outcome and reduce critical care resources required for 
patients undergoing thoracic surgery (30).
Another factor influencing the pro-inflammatory 
response during OLV is the type of general anesthesia 
used. Volatile anesthetics have been shown to induce dose 
and time-dependent immune-modulatory effects (35). 
Desflurane and sevoflurane suppress local alveolar cytokine 
pro-inflammatory release in the ventilated lung after OLV, 
while propofol seems not to produce this advantageous 
effect (36). In particular, volatile anesthesia with desflurane 
attenuates the immune response and causes, as compared 
to propofol, a minor alveolar release of inflammatory 
mediators such as ICAM-1, polymorphonuclear (PMN) 
A elastase, IL-8 and IL-10 (37). Desflurane at 1 MAC 
concentration produces bronchodilator effects, similar to 
that of sevoflurane and isoflurane, inducing a reduction 
of peak inspiratory pressure and an increase in dynamic 
compliance, which implies the protective effects on 
mechanical ventilation (38). In the present study, the choice 
of a volatile anesthetic as opposed to an intravenous one 
Table 3 Duration of OLV in the major studies
Studies Duration of OLV (min)
Yang et al. (13) 126±53 (CV), 120±41 (PV)
Michelet et al. (14) 89±29 (CV), 85±29 (PV) 
Sugasawa (6) 140.6±12.6
Shilling et al. (17) 71 (37–119, CV), 68 (20–117, PV)
Bastin et al. (22) 147 [121–196]
Present study 60.62±23.67 (CV), 67.50±20.72 (PV)
OLV, one-lung ventilation; CV, conventional ventilation; PV, 
protective ventilation.
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(in addition to the use of short term OLV) may have 
succeeded in preventing the activation of a local 
inflammatory cytokine response.
The use of less invasive surgical techniques and 
advanced anesthesia management in order to improve 
surgical outcomes is also the basis of fast track surgery 
programs (39,40). The focus of future studies will be 
to advance towards the standardization of fast track 
protocols in order to guarantee less invasive surgical 
techniques, (including nerve-sparing thoracotomy, 
muscle-sparing incisions and mini-thoracotomy), as 
well as effective anesthetic management, in the hope of 
achieving a perioperative negative fluid input balance 
through the use of restrictive fluid therapy and regional 
analgesic techniques, such as intrapleural intercostal 
nerve block. According to published findings, the use 
of an intrapleural intercostal nerve block in a mini-
thoracotomy reduces postoperative pain and contributes 
to improvement in postoperative outcomes after major 
pulmonary resection (41).
 The IFN-γ levels were below the detection threshold 
in 36/56 samples, whereas the IL-8 levels were above 
the upper limit of detection in 30/56 samples. To our 
knowledge, no studies evaluated the IFN-γ concentration 
in BAL during OLV, so we cannot speculate about the 
significance of IFN-γ values below the limit of detection. 
Concerning the recorded IL-8 concentration above range 
of detection, this value agrees with BAL concentration of 
IL-8 reported in literature (17,31). Unfortunately, due to 
the multiplexing form of the used analysis kit, we cannot 
measure IL-8 on diluted samples. Thus, IFN-γ and IL-8 
were excluded from further analysis.
During mechanical ventilation, a higher ventilator rate 
at 30 minutes of OLV (P=0.001) was required in the PV 
subgroup as compared to the CV subgroup, in order to 
achieve an optimal EtCO2 range. Additionally, the EtCO2 
and the PaCO2 (P=0.001) were higher in the PV subgroup. 
PaCO2 values were higher, but considered acceptable, 
nevertheless, in terms of permissive hypercapnia. Moderate 
hypercapnia potentiates HPV while also appearing to 
attenuate the cytokine response (42). Peripheral oxygen 
saturation at 30 minutes was higher in the CV subgroup 
(P=0.027). Only two cases of desaturation were registered 
(one in the CV subgroup and one in the PV subgroup), 
although, after verification of the DLT position through 
FOB, both were resolved with recruitment maneuvers 
without having to increase FiO2. In both cases, patients 
were not affected by chronic obstructive pulmonary disease 
(COPD) and had a FEV1 >90%. According to published 
findings (2), desaturation events during OLV are more 
likely in patients with better spirometric function prior 
to surgery. Slinger et al. (43) found that the lower the 
preoperative FEV1 was, the better oxygenation was during 
OLV. This paradoxical relationship may be explained 
by several mechanisms. A “dependent-lung effect”: 
the trapping of air in the ventilated lung can generate 
auto-PEEP during OLV decreasing the onset of atelectasis 
and improving oxygenation. A “non-dependent lung effect 
“: in COPD patients the non-ventilated lung may collapse 
more slowly, preserving oxygenation longer. A third 
mechanism is a redistribution of perfusion: patients with 
obstructive disease could be chronically subject to a degree 
of HPV and may have a different redistribution of the 
perfusion between the lungs during OLV (43).
One patient in the CV subgroup required a change 
in the venti lat ion mode from volume-control led 
ventilation to pressure-controlled ventilation due to a PIP 
value >35 cmH2O, with a setting to maintain the same VT. 
After the ventilation mode was changed, the mean P peak 
value was reduced to below 30 cmH2O, and the patient 
required no further assistance.
In the present study, systemic inflammation through 
blood sample analysis was not explored; this proved 
to be a potential limit of the study because blood tests 
could have been useful in determining the attribution of 
cytokine response in surgical trauma, lung cancer and 
other comorbidities. Moreover, there was no follow-up for 
patients after being discharged from the hospital which 
would have provided valuable insight into the long-term 
outcome. Finally, the non-randomized design of the study 
represented a further limit.
In conclusion, the present study showed no localized 
inflammatory cytokine response and no differences between 
different ventilatory strategies (regardless of whether a 
smaller or larger VT was employed) with a standardized 
application of PEEP and a short duration of OLV. The 
application of PEEP and short-term OLV could play 
a key role in preventing the development of VILI and 
postoperative respiratory complications.
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